SPC manufacturing waiver is good news for Europe

19 September 2018

An SPC manufacturing waiver should be extremely beneficial for Europe […]

Analysis of the proposal for a regulation of a manufacturing exception related to the SPC and aimed to make the European industry competitive

13 September 2018

Andriukaitis: SPC manufacturing waiver does not damage pharma innovation

12 June 2018

Generics driving pharmerging market growth? ‘There is still opportunity for EU’ says Medicines for Europe

22 May 2018

Up to 25,000 pharma jobs if EU alters patent rules

21 May 2018

Access to Biosimilars in EU Expected to Continue to Outpace US and Canada

26 April 2018

Stakeholders To Gather In London To Plan Biosimilar Market’s Future

17 April 2018

Increasing access to cancer medicines: what role do biosimilar medicines play?

9 April 2018

Generic industry boss: SPC manufacturing waiver won’t harm originators’ innovation

30 March 2018

El sistema español podría mejorar su coste-eficiencia con un plan nacional

27 February 2018